In log-rank test, low DAB2IP expression was also found to correlate closely with poor DSS of ESCC patients (median 14.77 vs. 34.50 months, P < 0.001; Table 2). The gene discussed is DAB2IP; the disease is esophageal squamous cell carcinoma.